ESCRS visual optics e-learning portal re-accredited for CME

Article

The EACCME accreditation is renewed through 2025.

A computer shows a virtual display of an online learning portal. Image credit: ©Deemerwha studio – stock.adobe.com

The ESCRS online learning portal was re-accredited through 2025. Image credit: ©Deemerwha studio – stock.adobe.com

The European Society of Cataract and Refractive Surgeons (ESCRS) confirmed that one of its online courses has been re-accredited via a brief announcement on Twitter.

The European Accreditation Council for Continuing Medical Education (EACCME) renewed the ESCRS Visual Optics Suite iLearn portal for CME.1 According to ESCRS, courses covered by the renewed accreditation include Visual Optics suite 1 (Visual Optics), 2 (Visual Function) and 3 (Imaging the Human Eye).

The EACCME accredits e-learning materials for two years at a time. Materials providers must follow rigorous guidelines in order for programmes to be accredited by the EACCME. Once the two-year accreditation period is over, CME providers must re-apply.2 E-learning programmes which receive the sign-off from the EACCME this year will remain accredited until 2025.

Previously, in February, the ESCRS Cataract Portal was reaccredited, extending that programme’s accreditation for two years.3 Topics in the cataract course catalog include Preparing for Surgery and Early Steps, Phacoemulsification and IOLs & Postoperative Refractive Outcome. The ESCRS said the iLearn platform boasts over 30 hours of content, including “surgical videos, diagrams, animations, quizzes and forums.”4

References

  1. @ESCRSofficial. We are happy to announce that The ESCRS Visual Optics Suite iLearn portal has been successfully re-accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide CME activity for medical specialists. Published June 9, 2023. Accessed June 12, 2023. https://twitter.com/ESCRSofficial/status/1667139918286520321
  2. Eaccme.uems.eu. EACCME Criteria for The Accreditation of Elearning Materials (ELM). Updated 2016. Accessed June 12, 2023. https://eaccme.uems.eu/img/user/files/UEMS2016_21%20-%20EACCME%202_0%20CRITERIA%20FOR%20THE%20ACCREDITATION%20OF%20ELM.pdf
  3. @ESCRSofficial. We are delighted to announce that the ESCRS #Cataract Portal has been reaccredited for another two years by the European Accreditation Council for Continuing Medical Education (EACCME)!. Published February 14, 2023. Accessed June 12, 2023. https://twitter.com/ESCRSofficial/status/1625496062969667585
  4. @ESCRSofficial. ESCRS iLEARN: This online learning platform is free for #ESCRS members. Over 30 hours of interactive, assessed and accredited elearning content, including surgical videos, diagrams, animations, quizzes and forums. #ophthalmology https://elearning.escrs.org/login/index.php. Published June 27, 2018. Accessed June 12, 2023. https://twitter.com/ESCRSofficial/status/1012015246901497858

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.